A One-Stop-Shop Gene to Antibody Partner Genovac is a contract research and manufacturing organization committed to positioning our clients for the successful development of new transformative drugs and diagnostics. Genovac specializes in antibody discovery and production against challenging targets. Our unique combination of genetic immunization, multiple host species, multiple single B cell platforms, and state-of-the-art production facilities enables us to serve as your one-stop-shop Gene to Antibody partner.
| Website | https://genovac.com/ |
| Revenue | $26.4 million |
| Employees | 23 (19 on RocketReach) |
| Founded | 1999 |
| Address | 1810 NDSU Research Circle North, Fargo, North Dakota, US |
| Industry | Biotechnology Research |
| Keywords | Contract Research Organization, Antibody Engineering, Cro Services, Antibody Production, Cmo Services, Therapeutic Antibodies, Pharmaceutical Manufacturing, New Drug Development, Biopharmaceutical Development, Biologics Manufacturing, Transformative Medicine, Drug Discovery, Protein Engineering, Precision Medicine, Diagnostic Development, Immunology Research, Gene Therapy, Biotechnology Research, Pharmaceutical Research |
| Competitors | Thermo Fisher Scientific, Genentech, Amgen, Lonza, Edelman, Bio-Rad Laboratories, MEDGENOME, Abzena, Horizon Discovery, 维亚生物科技(上海)有限公司 +40 more (view full list) |
Looking for a particular Genovac employee's phone or email?
The Genovac annual revenue was $26.4 million in 2026.
Brian Walters is the CEO of Genovac.
19 people are employed at Genovac.
Genovac is based in Fargo, North Dakota.